FFPRHC Guidance (October 2003): First Prescription of Combined Oral Contraception
Author:
- Faculty of Family Planning and Reproductive Health Care, Clinical Effectiveness UnitFUFaculty of Family Planning and Reproductive Health Care, Clinical Effectiveness Unit
- 1 October 2003
- journal article
- guideline
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 29 (4) , 209-222
Abstract
This Guidance provides information for clinicians on the steps to be taken before providing a woman with her first prescription for combined oral contraception. It updates and replaces previous Faculty Guidance.1 A key to the grades of recommendations, based on levels of evidence, is given at the end of this document. Details of the methods used by the Clinical Effectiveness Unit (CEU) in developing this Guidance, and evidence tables summarising the research basis of the recommendations, are available on the Faculty website (www.ffprhc.org.uk). Abbreviations used include: blood pressure (BP), body mass index (BMI), bone mineral density (BMD), breakthrough bleeding (BTB), British National Formulary (BNF), combined oral contraception (COC), Committee on Safety of Medicines (CSM), confidence interval (CI), deep vein thrombosis (DVT), emergency contraception (EC), ethinyl oestradiol (EE), Faculty Aid to Continuing Professional Development Topics (FACT), Family Planning Association (fpa), follicle-stimulating hormone (FSH), general practitioner (GP), intermenstrual bleeding (IMB), luteinising hormone (LH), microgram (mg), myocardial infarction (MI), odds ratio (OR), oral contraception (OC), pulmonary embolism (PE), relative risk (RR), Scottish Intercollegiate Guideline Network (SIGN), sexually transmitted infection (STI), Summary of Product Characteristics (SPCs), venous thromboembolism (VTE), World Health Organization (WHO), WHO Medical Eligibility Criteria (WHOMEC), WHO Selected Practice Recommendations (WHOSPR).Keywords
This publication has 84 references indexed in Scilit:
- Mortality in relation to oral contraceptive use and cigarette smokingThe Lancet, 2003
- Oral contraceptives and venous thromboembolism: a five-year national case-control study☆Contraception, 2002
- Family history and risk of venous thromboembolism with oral contraceptionBMJ, 2001
- Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational studyBMJ, 2001
- Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 ?g ethinylestradiol and 75 g gestodeneThe European Journal of Contraception & Reproductive Health Care, 2001
- Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysisBMJ, 2000
- A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptivesBritish Journal of Clinical Pharmacology, 2000
- Recommendations on the Risk of Ischaemic Stroke Associated With Use of Combined Oral Contraceptives and Hormone Replacement Therapy in Women With MigraineCephalalgia, 2000
- Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control studyThe Lancet, 1996
- Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study.BMJ, 1989